NCT02007603View on ClinicalTrials.gov

Concentration of Ampicillin / Sulbactam and Amoxicillin / Clavulanic Acid in the Blood During Renal Replacement Therapy in Longterm Renal Replacement Therapy Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

February 28, 2015

Study Completion Date

May 31, 2017

Conditions
Infection During Hemodialysis
Interventions
DRUG

Administration of Amoxicillin / clavulanic acid

Patients receive amoxicillin / clavulanic acid due to clinical necessity

DRUG

Ampicillin / sulbactam

Patients receive ampicillin / sulbactam due to clinical necessity

PROCEDURE

Blooddraws for pharmacokinetic profiling

Blood will be sampled at multiple timepoints during multiple hemodialysis sessions

Trial Locations (1)

1090

Medical University of Vienna, Vienna

All Listed Sponsors
lead

Medical University of Vienna

OTHER

NCT02007603 - Concentration of Ampicillin / Sulbactam and Amoxicillin / Clavulanic Acid in the Blood During Renal Replacement Therapy in Longterm Renal Replacement Therapy Patients | Biotech Hunter | Biotech Hunter